We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Early Onset Diabetes Shortens Lifespan by Years

By HospiMedica International staff writers
Posted on 23 Aug 2018
A new study reveals that women who develop type 1 diabetes (T1D) before the age of 10 years die an average of nearly 18 years earlier than women who do not have diabetes.

Researchers at Sahlgrenska Academy (SA; Göteborg, Sweden), the University of Gothenburg (Sweden), the Swedish National Diabetes Register, and other institutions conducted a Swedish nationwide, register-based cohort study involving 27,195 people with T1D and 135,178 matched controls in order to stratify age of onset as a risk factor. More...
Study participants were categorized into five groups, according to age at diagnosis: 0–10 years, 11–15 years, 16–20 years, 21–25 years and 26–30 years. During the median follow-up period of 10 years, 959 T1D participants and 1,501 controls died.

The researcher analyzed the data in order to estimate excess risk of all-cause mortality, cardiovascular mortality, non-cardiovascular mortality, acute myocardial infarction (MI), stroke, cardiovascular disease (a composite of acute myocardial infarction and stroke), coronary heart disease, heart failure (HF) and atrial fibrillation (AF). The results revealed that age at onset of T1D is an important determinant of survival and cardiovascular outcomes, with highest excess risk observed in women.

The probability of severe cardiovascular disease proved to be 30 times higher for those who developed T1D before the age of 10 years than for controls. The highest increase in mortality risk involved heart attacks in women who developed T1D before the age of ten, 90 times higher than that of the controls, shortening their life by an average of 17.7 years. Men with T1D in the corresponding situation lost 14.2 years of life. Diagnosis of T1D at 26-30 years resulted in a corresponding risk increase by a factor of six, or 10 years of life. The study was published on August 11, 2018, in The Lancet.

“These are disappointing and previously unknown figures. The study suggests that we must make an even greater effort to aggressively treat patients diagnosed at an early age to reduce the risk of complications and premature death,” said lead author Araz Rawshani, PhD, of Sahlgrenska Academy. “At the same time, the study must also be viewed in the light of the tremendous progress that has been made in the past few decades. Those who live with diabetes today, and those who will acquire the disease, will enjoy longer and healthier lives in the years to come.”

T1D is an autoimmune disease in which a person's pancreas stops producing insulin. It can impact both children and adults at any age, causing dependence on multiple daily injections of insulin or an insulin pump. Serious short and long term complications stemming from high blood sugar levels can lead to kidney failure, blindness, nerve damage, heart attack, and stroke. Low levels can be life-threatening, particularly at night when they are most difficult to manage.

Related Links:
Sahlgrenska Academy
University of Gothenburg

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
12-Channel ECG
CM1200B
New
Multifunctional Patient Floor Lift
Maxi Move 5
New
Portable Digital Floor Scale
DR400C
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The Minder Implant can record brain activity continuously for very long periods (Photo courtesy of Epiminder)

Implantable Device Continuously Monitors Brain Activity in Epileptic Patients

Epilepsy is one of the most prevalent and serious chronic neurological disorders, impacting around 52 million people globally. It is characterized by recurrent seizures, which are caused by abnormal electrical... Read more

Surgical Techniques

view channel
Image: The engine-free, nonlinear, flexible, micro-robotic platform leverages AI to optimize GBM treatment (Photo courtesy of Symphony Robotics)

First-Ever MRI-Steerable Micro-Robotics to Revolutionize Glioblastoma Treatment

Glioblastoma Multiforme (GBM) is one of the most aggressive and difficult-to-treat brain cancers. Traditional surgical procedures, such as craniotomies, involve significant invasiveness, requiring large... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.